Comparing bone marrow transplantation with immune therapy for severe aplastic anemia in young patients

1/2A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia

NIH-funded research Medical College of Wisconsin · NIH-11060990

This study is looking at whether bone marrow transplants from unrelated donors or immune suppression therapy works better for kids and young adults with newly diagnosed severe aplastic anemia, especially since not everyone has a sibling who can donate bone marrow.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionMedical College of Wisconsin NIH-funded
Lab location1 site (Milwaukee, United States)
Project IDNIH-11060990 on NIH RePORTER

What this research studies

This research investigates the effectiveness of bone marrow transplantation (BMT) from unrelated donors compared to immune suppression therapy (IST) for treating newly diagnosed severe aplastic anemia (SAA) in pediatric and young adult patients. The study aims to determine which treatment provides better outcomes, considering that many patients do not have a suitable sibling donor for BMT. Participants will be randomly assigned to receive either treatment, and their health outcomes will be monitored over time. The research is being conducted by a consortium of pediatric specialists to ensure comprehensive care and support for the patients involved.

Who could benefit from this research

Good fit: Ideal candidates for this research are pediatric and young adult patients newly diagnosed with severe aplastic anemia.

Not a fit: Patients who have already undergone treatment for severe aplastic anemia or those with other significant health conditions may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could provide a more effective treatment option for young patients with severe aplastic anemia, potentially improving survival rates and quality of life.

How similar studies have performed: Previous research has shown promising outcomes for unrelated donor bone marrow transplantation in similar patient populations, indicating that this approach may be effective.

Where this research is happening

Milwaukee, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.